Elmind Capital, LP Concentrated Active

Location: New York, NY

CIK: 0002052213 · Show all filings

Period: Q4 2025 (Next →)

Filing Date: Feb 17, 2026

Total Value: $339M (100.0% shares, 0.0% debt)

Holdings (34)

COGT COGENT BIOSCIENCES INC 12.3%
Value $41.58M Shares 1,170,740 Est. Cost $28.11 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 11.5%
Value $38.97M Shares 1,855,000 Est. Cost $17.45 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 7.9%
Value $26.72M Shares 858,631 Est. Cost $27.43 Unrealized 0.0%
VERA VERA THERAPEUTICS INC 7.2%
Value $24.43M Shares 482,500 Est. Cost $35.52 Unrealized 0.0%
CLDX CELLDEX THERAPEUTICS INC NEW 6.9%
Value $23.49M Shares 865,000 Est. Cost $26.34 Unrealized 0.0%
CGON CG ONCOLOGY INC 6.0%
Value $20.45M Shares 492,500 Est. Cost $41.38 Unrealized 0.0%
BCRX BIOCRYST PHARMACEUTICALS INC 4.9%
Value $16.77M Shares 2,150,000 Est. Cost $7.23 Unrealized 0.0%
PCVX VAXCYTE INC 4.0%
Value $13.45M Shares 291,500 Est. Cost $44.73 Unrealized 0.0%
BEAM BEAM THERAPEUTICS INC 3.9%
Value $13.2M Shares 476,338 Est. Cost $25.51 Unrealized 0.0%
PHVS PHARVARIS N V 3.9%
Value $13.2M Shares 475,750 Est. Cost $24.09 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 3.8%
Value $12.94M Shares 801,300 Est. Cost $13.24 Unrealized 0.0%
DYNAVAX TECHNOLOGIES CORP 3.1%
Value $10.46M Shares 679,900 Est. Cost $15.38 Unrealized
TYRA TYRA BIOSCIENCES INC 2.7%
Value $9.201M Shares 350,000 Est. Cost $18.37 Unrealized 0.0%
NRIX NURIX THERAPEUTICS INC 2.6%
Value $8.726M Shares 460,000 Est. Cost $14.37 Unrealized 0.0%
WVE WAVE LIFE SCIENCES LTD 2.2%
Value $7.613M Shares 447,846 Est. Cost $10.16 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 2.0%
Value $6.655M Shares 211,000 Est. Cost $24.26 Unrealized 0.0%
KRYS KRYSTAL BIOTECH INC 1.6%
Value $5.424M Shares 22,000 Est. Cost $210.47 Unrealized 0.0%
UTHR UNITED THERAPEUTICS CORP DEL 1.6%
Value $5.36M Shares 11,000 Est. Cost $465.69 Unrealized 0.0%
BMRN BIOMARIN PHARMACEUTICAL INC 1.4%
Value $4.873M Shares 82,000 Est. Cost $54.44 Unrealized 0.0%
RLAY RELAY THERAPEUTICS INC 1.3%
Value $4.543M Shares 536,946 Est. Cost $7.14 Unrealized 0.0%
TVTX TRAVERE THERAPEUTICS INC 1.2%
Value $4.203M Shares 110,000 Est. Cost $32.52 Unrealized 0.0%
PTGX PROTAGONIST THERAPEUTICS INC 1.0%
Value $3.319M Shares 38,000 Est. Cost $81.85 Unrealized 0.0%
CGEM CULLINAN THERAPEUTICS INC 0.9%
Value $3.208M Shares 310,000 Est. Cost $9.02 Unrealized 0.0%
LQDA LIQUIDIA CORPORATION 0.9%
Value $3.104M Shares 90,000 Est. Cost $28.47 Unrealized 0.0%
CTMX CYTOMX THERAPEUTICS INC 0.9%
Value $2.982M Shares 700,000 Est. Cost $3.80 Unrealized 0.0%
URGN UROGEN PHARMA LTD 0.7%
Value $2.342M Shares 100,000 Est. Cost $21.69 Unrealized 0.0%
IMCR IMMUNOCORE HLDGS PLC 0.6%
Value $2.022M Shares 58,248 Est. Cost $34.71 Unrealized
DSGN DESIGN THERAPEUTICS INC 0.6%
Value $1.95M Shares 207,900 Est. Cost $7.83 Unrealized 0.0%
ENGN ENGENE HOLDINGS INC 0.6%
Value $1.896M Shares 210,000 Est. Cost $8.01 Unrealized 0.0%
ALEC ALECTOR INC 0.4%
Value $1.404M Shares 900,000 Est. Cost $1.77 Unrealized 0.0%
AMLX AMYLYX PHARMACEUTICALS INC 0.4%
Value $1.353M Shares 112,000 Est. Cost $13.58 Unrealized 0.0%
APLS APELLIS PHARMACEUTICALS INC 0.4%
Value $1.256M Shares 50,000 Est. Cost $23.46 Unrealized 0.0%
SUPN SUPERNUS PHARMACEUTICALS INC 0.3%
Value $994K Shares 20,000 Est. Cost $48.62 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 0.2%
Value $744K Shares 30,000 Est. Cost $20.07 Unrealized 0.0%